"Designing Growth Strategies is in our DNA"

Critical Care Antiarrhythmic Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Beta Blockers, Calcium Channel Blockers, Sodium Channel Blockers, Potassium Channel Blockers, and Others), By Disease Type (Supraventricular Arrhythmias, Ventricular Arrhythmias, and Others), and Regional Forecast, 2020-2027

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI104703

 

Table of Content:

  1. . Introduction                                                                           
    1. Research Scope                                                                                                                                              
    2. Market Segmentation                                                                                                                 
    3. Research Methodology                                                                                                               
    4. Definitions and Assumptions                                                                                                    
  2. Executive Summary                                                                                                                               
  3. Market Dynamics                                                                                                                                                    
    1. Market Drivers                                                                                                                               
    2. Market Restraints                                                                                                                                         
    3. Market Opportunities                                                                                                                  
  4. Key Insights                                                                                                                                                               
    1. Epidemiology of Arrhythmias, For Key Countries/ Regions                                                           
    2. Prevalence of Cardiovascular Disease - For Key Countries/ Regions                                          
    3. Pipeline Analysis                                                                                                                                            
    4. New Product Launches                                                                                                               
    5. Key Industry Developments - Partnerships, Mergers & Acquisitions                                         
    6. Impact of COVID-19 Pandemic for Critical Care Antiarrhythmic Drugs Market     
  5. Global Critical Care Antiarrhythmic Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary                                                                                                                             
    2. Market Analysis, Insights and Forecast – By Drug Class                                                  
      1. Beta Blockers
      2. Calcium Channel Blockers                                                                                                
      3. Sodium Channel Blockers                                                                                                 
      4. Potassium Channel Blockers                                                                                            
      5. Others                                                                                                                                      
    3. Market Analysis, Insights and Forecast – By Disease Type                                                            
      1. Supraventricular arrhythmias
      2. Ventricular arrhythmias                                                                                    
      3. Others                                                                                                                                      
    4. Market Analysis, Insights and Forecast – By Countries/ Sub regions                                         
      1. North America                                                                                                                      
      2. Europe                                                                                                                                     
      3. Asia Pacific
      4. Latin America                                                                                                                        
      5. Middle East & Africa                                                                                                           
  6. North America Critical Care Antiarrhythmic Drugs Market Analysis, Insights and Forecast, 2016-2027                                                                                                                                                                        
    1. Key Findings / Summary                                                                                                                             
    2. Market Analysis – By Drug Class                                                                                              
      1. Beta Blockers                                                                                                        
      2. Calcium Channel Blockers                                                                                                
      3. Sodium Channel Blockers                                                                                                 
      4. Potassium Channel Blockers                                                                                            
      5. Others                                                                                                                                      
    3. Market Analysis, Insights and Forecast – By Disease Type                                                            
      1. Supraventricular arrhythmias                                                                                         
      2. Ventricular arrhythmias
      3. Others                                                                                                                                      
    4. Market Analysis, Insights and Forecast – By Country                                                                      
      1. U.S.
      2. Canada                                                                                                                                     
  7. Europe Critical Care Antiarrhythmic Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary                                                                                                                             
    2. Market Analysis – By Drug Class                                                                                                              
      1. Beta Blockers
      2. Calcium Channel Blockers                                                                                                                
      3. Sodium Channel Blockers
      4. Potassium Channel Blockers                                                                            
      5. Others                                                                                                                                      
    3. Market Analysis, Insights and Forecast – By Disease Type                                                            
      1. Supraventricular arrhythmias
      2. Ventricular arrhythmias                                                                                                    
      3. Others                                                                                                                                      
    4. Market Analysis, Insights and Forecast – By Countries/ Sub-region                                          
      1. U.K.                                                                                                                                           
      2. Germany
      3. France                                                                                                                                      
      4. Spain         
      5. Italy           
      6. Scandinavia            
      7. Rest of Europe                      
  8. Asia Pacific Critical Care Antiarrhythmic Drugs Market Analysis, Insights and Forecast, 2016-2027                                                                                                                                                                               
    1. Key Findings / Summary             
    2. Market Analysis – By Drug Class
      1. Beta Blockers        
      2. Calcium Channel Blockers                
      3. Sodium Channel Blockers 
      4. Potassium Channel Blockers                            
      5. Others      
    3. Market Analysis, Insights and Forecast – By Disease Type            
      1. Supraventricular arrhythmias
      2. Ventricular arrhythmias                                                                                    
      3. Others                                                                                                                                      
    4. Market Analysis, Insights and Forecast – By Countries/ Sub-region                                          
      1. Japan                                                                                                                                        
      2. China
      3. India                                                                                                                                          
      4. Australia
      5. Southeast Asia                                                                                                                      
      6. Rest of Asia Pacific                                                                                                               
  9. Latin America Critical Care Antiarrhythmic Drugs Market Analysis, Insights and Forecast, 2016-2027                                                                                                                                                                          
    1. Key Findings / Summary             
    2. Market Analysis – By Drug Class
      1. Beta Blockers                        
      2. Calcium Channel Blockers
      3. Sodium Channel Blockers                 
      4. Potassium Channel Blockers            
      5. Others                                                                                                                                      
    3. Market Analysis, Insights and Forecast – By Disease Type
      1. Supraventricular arrhythmias
      2. Ventricular arrhythmias                    
      3. Others                      
    4. Market Analysis, Insights and Forecast – By Countries/ Sub regions
      1. Brazil                                         
      2. Mexico                     
      3. Rest of Latin America                                                                                                         
  10. Middle East & Africa Critical Care Antiarrhythmic Drugs Market Analysis, Insights and Forecast, 2016-2027     
    1. Key Findings / Summary               
    2. Market Analysis – By Drug Class
      1. Beta Blockers    
      2. Calcium Channel Blockers            
      3. Sodium Channel Blockers                             
      4. Potassium Channel Blockers       
      5. Others                 
    3. Market Analysis, Insights and Forecast – By Disease Type                                                              
      1. Supraventricular arrhythmias                                                                                     
      2. Ventricular arrhythmias
      3. Others                                                                                                 
    4. Market Analysis, Insights and Forecast – By Countries/ Sub regions                                           
      1. South Africa                                                                                                                       
      2. GCC
      3. Rest of Middle East & Africa       
  11. Competitive Analysis             
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Pfizer Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)                
      2. GlaxoSmithKline plc
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Sanofi  
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Mylan N.V.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Upsher-Smith Laboratories, LLC.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Baxter  
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Mayne Pharma
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Amomed Pharma GmbH              
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Other Prominent Players
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations

List of figures

Figure 1:  Global Critical Care Antiarrhythmic Drugs Market Revenue Breakdown (US$ Mn, %) by Region, 2019 & 2027

Figure 2:  Global Critical Care Antiarrhythmic Drugs Market Value Share (%), by Drug Class, 2019 & 2027

Figure 3:  Global Critical Care Antiarrhythmic Drugs Market Forecast (US$ Mn), by Beta Blockers, 2016-2027

Figure 4:  Global Critical Care Antiarrhythmic Drugs Market Forecast (US$ Mn), by Calcium Channel Blockers, 2016-2027

Figure 5:  Global Critical Care Antiarrhythmic Drugs Market Forecast (US$ Mn), by Sodium Channel Blockers, 2016-2027

Figure 6:  Global Critical Care Antiarrhythmic Drugs Market Forecast (US$ Mn), by Potassium Channel Blockers, 2016-2027

Figure 7:  Global Critical Care Antiarrhythmic Drugs Market Forecast (US$ Mn), by Others, 2016-2027

Figure 8:  Global Critical Care Antiarrhythmic Drugs Market Value Share (%), by Disease Type, 2019 & 2027

Figure 9:  Global Critical Care Antiarrhythmic Drugs Market Forecast (US$ Mn), by Supraventricular arrhythmias, 2016-2027

Figure 10:  Global Critical Care Antiarrhythmic Drugs Market Forecast (US$ Mn), by Ventricular arrhythmias, 2016-2027

Figure 11:  Global Critical Care Antiarrhythmic Drugs Market Forecast (US$ Mn), by Others, 2016-2027

Figure 12:  Global Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), by Region, 2019 & 2027

Figure 13:  North America Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), by Drug Class, 2019 & 2027

Figure 14:  North America Critical Care Antiarrhythmic Drugs Market Value Share (%), by Drug Class, 2019

Figure 15:  North America Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), by Disease Type, 2019 & 2027

Figure 16:  North America Critical Care Antiarrhythmic Drugs Market Value Share (%), by Disease Type, 2019

Figure 17:  North America Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), By Country, 2019 & 2027

Figure 18:  North America Critical Care Antiarrhythmic Drugs Market Value Share (%), By Country, 2019

Figure 19:  Europe Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), by Drug Class, 2019 & 2027

Figure 20:  Europe Critical Care Antiarrhythmic Drugs Market Value Share (%), by Drug Class, 2019

Figure 21:  Europe Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), by Disease Type, 2019 & 2027

Figure 22:  Europe Critical Care Antiarrhythmic Drugs Market Value Share (%), by Disease Type, 2019

Figure 23:  Europe Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), By Country/ Sub-region, 2019 & 2027

Figure 24:  Europe Critical Care Antiarrhythmic Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 25:  Asia Pacific Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), by Drug Class, 2019 & 2027

Figure 26:  Asia Pacific Critical Care Antiarrhythmic Drugs Market Value Share (%), by Drug Class, 2019

Figure 27:  Asia Pacific Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), by Disease Type, 2019 & 2027

Figure 28:  Asia Pacific Critical Care Antiarrhythmic Drugs Market Value Share (%), by Disease Type, 2019

Figure 29:  Asia Pacific Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), By Country/ Sub-region, 2019 & 2027

Figure 30:  Asia Pacific Critical Care Antiarrhythmic Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 31:  Latin America Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), by Drug Class, 2019 & 2027

Figure 32:  Latin America Critical Care Antiarrhythmic Drugs Market Value Share (%), by Drug Class, 2019

Figure 33:  Latin America Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), by Disease Type, 2019 & 2027

Figure 34:  Latin America Critical Care Antiarrhythmic Drugs Market Value Share (%), by Disease Type, 2019

Figure 35:  Latin America Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), By Country/ Sub-region, 2019 & 2027

Figure 36:  Latin America Critical Care Antiarrhythmic Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 37:  Middle East & Africa Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), by Drug Class, 2019 & 2027

Figure 38:  Middle East & Africa Critical Care Antiarrhythmic Drugs Market Value Share (%), by Drug Class, 2019

Figure 39:  Middle East & Africa Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), by Disease Type, 2019 & 2027

Figure 40:  Middle East & Africa Critical Care Antiarrhythmic Drugs Market Value Share (%), by Disease Type, 2019

Figure 41:  Middle East & Africa Critical Care Antiarrhythmic Drugs Market Value (US$ Mn), By Country/ Sub-region, 2019 & 2027

Figure 42:  Middle East & Africa Critical Care Antiarrhythmic Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 43:  Global Critical Care Antiarrhythmic Drugs Market Share (%), By Company, 2019

List of Tables

Table 1:  Global Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2016–2027

Table 2:  Global Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2016–2027

Table 3:  Global Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Region, 2016-2027

Table 4:  North America Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2016-2027

Table 5:  North America Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2016-2027

Table 6:  North America Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, By Country, 2016-2027

Table 7:  Europe Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2016-2027

Table 8:  Europe Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2016-2027

Table 9:  Europe Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2016-2027

Table 10:  Asia Pacific Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2016-2027

Table 11:  Asia Pacific Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2016-2027

Table 12:  Asia Pacific Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2016-2027

Table 13:  Latin America Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2016-2027

Table 14:  Latin America Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2016-2027

Table 15:  Latin America Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2016-2027

Table 16:  Middle East & Africa Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2016-2027

Table 17:  Middle East & Africa Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, by Disease Type, 2016-2027

Table 18:  Middle East & Africa Critical Care Antiarrhythmic Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2016-2027

Critical Care Antiarrhythmic Drugs Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase